Atherosclerosis: Identifying risks and improving outcomes
Learn more
This website is intended exclusively for healthcare professionals residing and/or working in the UAE.



.png)

ADA/EASD recommend considering combination injectables therapy of basal insulin/GLP-1 RA (Such as Soliqua®) as valuable treatment option to provide adequate efficacy for achieving and maintaining glycemic goals.